Tortugas Neuroscience, Inc.
Clinical trials sponsored by Tortugas Neuroscience, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- An Open-Label phase 1 study to assess the safety, tolerability, and pharmacokinetics of a single dose of a new tablet formulation of TRTL-729 in healthy adults Results expected Jan 2027 (estimated)
- Can a new pill silence the ringing in your ears? Results expected Aug 2027 (estimated)
-
Can a new pill silence the ringing in your ears?
Symptom relief Not yet recruitingThis Phase 2a trial is testing an experimental drug called TRTL-913 to see if it is safe and might help reduce tinnitus, the perception of ringing or buzzing in the ears. The study has two parts: first, healthy adults will receive the drug or a placebo to check safety and how the…
Phase 2 • Sponsor: Tortugas Neuroscience, Inc. • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
An Open-Label phase 1 study to assess the safety, tolerability, and pharmacokinetics of a single dose of a new tablet formulation of TRTL-729 in healthy adults
Not yet recruitingThis study assesses the safety, tolerability, and pharmacokinetics (PK) of the tablet formulation of TRTL-729 in healthy adults.
Phase 1 • Sponsor: Tortugas Neuroscience, Inc.
Last updated Sep 09, 2026 17:00 UTC